Xtant Medical Holdings, Inc. - Common Stock (XTNT) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
XTNT on NYSE
Shares outstanding
140,036,400
Price per share
$0.65
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
81,384,599
Total reported value
$63,802,481
% of total 13F portfolios
0%
Share change
+968,610
Value change
+$769,162
Number of holders
34
Price from insider filings
$0.65
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Xtant Medical Holdings, Inc. - Common Stock (XTNT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 49% 0% $50,543,166 68,394,000 0% Nantahala Capital Management, LLC 01 Aug 2025
LYTTON LAURENCE W 5.5% -19% $5,545,441 -$1,268,237 7,702,002 -19% LYTTON LAURENCE W 31 Dec 2025

As of 31 Dec 2025, 34 institutional investors reported holding 81,384,599 shares of Xtant Medical Holdings, Inc. - Common Stock (XTNT). This represents 58% of the company’s total 140,036,400 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 49% 68,394,000 0% 3.2% $53,620,896
AWM Investment Company, Inc. 4.7% 6,594,121 0% 0.5% $5,169,791
VANGUARD GROUP INC 1.6% 2,272,591 -3.5% 0% $1,781,712
RENAISSANCE TECHNOLOGIES LLC 0.66% 919,860 +29% 0% $721,170
GEODE CAPITAL MANAGEMENT, LLC 0.35% 491,949 0% 0% $385,788
Crescent Grove Advisors, LLC 0.29% 412,024 0% 0.03% $323,027
Hillsdale Investment Management Inc. 0.26% 362,200 0.01% $283,965
CITADEL ADVISORS LLC 0.21% 287,798 +259% 0% $225,634
NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.2% 280,000 0% 0.19% $219,520
ACADIAN ASSET MANAGEMENT LLC 0.14% 194,062 0% $149,000
MILLENNIUM MANAGEMENT LLC 0.14% 190,846 -21% 0% $149,623
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.12% 164,100 0% 0% $128,654
BlackRock, Inc. 0.08% 115,782 -3.8% 0% $90,773
Mink Brook Asset Management LLC 0.08% 109,466 0% 0.05% $85,821
WIREGRASS INVESTMENT MANAGEMENT LLC 0.07% 103,000 0% 0.07% $80,752
Tradition Wealth Management, LLC 0.07% 100,297 0.01% $78,633
Private Advisor Group, LLC 0.06% 85,000 -31% 0% $66,640
TWO SIGMA SECURITIES, LLC 0.06% 77,350 0.01% $60,642
NORTHERN TRUST CORP 0.04% 57,464 -2% 0% $45,052
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.03% 36,158 0% $28,348
STATE STREET CORP 0.02% 31,266 0% 0% $24,513
PRUDENTIAL FINANCIAL INC 0.02% 23,400 0% 0% $18,346
LAZARD ASSET MANAGEMENT LLC 0.02% 22,720 0% $17,812
Kestra Advisory Services, LLC 0.01% 20,000 0% $15,680
JANE STREET GROUP, LLC 0.01% 19,206 0% $15,058

Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 81,384,599 $63,802,481 +$769,162 $0.78 34
2025 Q3 80,064,653 $51,958,020 +$59,666 $0.65 29
2025 Q2 79,963,210 $59,092,411 +$9,527,080 $0.74 29
2025 Q1 96,332,001 $45,274,819 -$166,227 $0.47 26
2024 Q4 96,692,530 $42,834,946 -$1,064,038 $0.44 28
2024 Q3 98,215,048 $66,126,833 +$5,325,340 $0.68 27
2024 Q2 90,066,890 $56,742,224 -$435,632 $0.63 26
2024 Q1 90,374,385 $105,738,087 +$205,479 $1.17 33
2023 Q4 90,202,353 $101,928,562 -$82,302 $1.13 31
2023 Q3 90,276,097 $99,304,130 +$9,366,353 $1.10 28
2023 Q2 81,765,290 $76,033,381 -$53,515 $0.93 19
2023 Q1 81,854,114 $52,181,371 -$34,628 $0.64 21
2022 Q4 81,903,507 $54,055,554 +$144,724 $0.66 19
2022 Q3 81,682,735 $58,794,209 +$779,674 $0.72 12
2022 Q2 80,613,065 $41,878,151 +$4,656 $0.52 12
2022 Q1 80,534,844 $54,787,198 -$46,947 $0.68 15
2021 Q4 80,663,007 $45,172,000 +$87,373 $0.56 17
2021 Q3 80,508,571 $89,363,000 -$2,471,600 $1.11 12
2021 Q2 82,710,575 $134,818,000 +$13,336,837 $1.63 14
2021 Q1 74,502,096 $175,824,000 +$1,768,228 $2.36 14
2020 Q4 73,761,114 $88,226,000 +$76,215,399 $1.20 11
2020 Q3 10,131,401 $8,345,000 -$186,747 $0.82 12
2020 Q2 10,345,548 $9,310,000 -$902,433 $0.90 10
2020 Q1 11,672,319 $7,820,000 +$9,453 $0.67 11
2019 Q4 11,656,858 $18,653,000 -$32,980 $1.60 9
2019 Q3 11,675,943 $33,159,000 -$11,600 $2.84 12
2019 Q2 11,679,733 $35,039,000 +$50,902 $3.00 10
2019 Q1 11,662,801 $35,571,000 -$210,500 $3.05 9
2018 Q4 11,735,030 $18,894,000 +$69,173 $1.61 11
2018 Q3 11,691,562 $45,015,000 +$2,792,758 $3.85 11
2018 Q2 10,963,855 $60,850,000 +$2,123,813 $5.55 12
2018 Q1 10,569,679 $83,108,926 +$83,108,926 $7.89 11